These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 23280993)

  • 61. Early Abrogation of Gelatinase Activity Extends the Time Window for tPA Thrombolysis after Embolic Focal Cerebral Ischemia in Mice.
    Chen S; Chen Z; Cui J; McCrary ML; Song H; Mobashery S; Chang M; Gu Z
    eNeuro; 2018; 5(3):. PubMed ID: 29963617
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke.
    Simão F; Ustunkaya T; Clermont AC; Feener EP
    Blood; 2017 Apr; 129(16):2280-2290. PubMed ID: 28130211
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Annexin A2 Plus Low-Dose Tissue Plasminogen Activator Combination Attenuates Cerebrovascular Dysfunction After Focal Embolic Stroke of Rats.
    Fan X; Jiang Y; Yu Z; Liu Q; Guo S; Sun X; van Leyen K; Ning M; Gao X; Lo EH; Wang X
    Transl Stroke Res; 2017 Dec; 8(6):549-559. PubMed ID: 28580536
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MRI evaluation of BBB disruption after adjuvant AcSDKP treatment of stroke with tPA in rat.
    Ding G; Zhang Z; Chopp M; Li L; Zhang L; Li Q; Wei M; Jiang Q
    Neuroscience; 2014 Jun; 271():1-8. PubMed ID: 24769225
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.
    Tsuji K; Aoki T; Tejima E; Arai K; Lee SR; Atochin DN; Huang PL; Wang X; Montaner J; Lo EH
    Stroke; 2005 Sep; 36(9):1954-9. PubMed ID: 16051896
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Extension of Tissue Plasminogen Activator Treatment Window by Granulocyte-Colony Stimulating Factor in a Thromboembolic Rat Model of Stroke.
    Dela Peña IC; Yang S; Shen G; Fang Liang H; Solak S; Borlongan CV
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29857523
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke.
    Lapchak PA; Chapman DF; Zivin JA
    Stroke; 2000 Dec; 31(12):3034-40. PubMed ID: 11108768
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Combination treatment with N-acetyl-seryl-aspartyl-lysyl-proline and tissue plasminogen activator provides potent neuroprotection in rats after stroke.
    Zhang L; Chopp M; Teng H; Ding G; Jiang Q; Yang XP; Rhaleb NE; Zhang ZG
    Stroke; 2014 Apr; 45(4):1108-14. PubMed ID: 24549864
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tissue plasminogen activator mediates deleterious complement cascade activation in stroke.
    Zhao XJ; Larkin TM; Lauver MA; Ahmad S; Ducruet AF
    PLoS One; 2017; 12(7):e0180822. PubMed ID: 28700732
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Oxygen glucose deprivation switches the transport of tPA across the blood-brain barrier from an LRP-dependent to an increased LRP-independent process.
    Benchenane K; Berezowski V; Fernández-Monreal M; Brillault J; Valable S; Dehouck MP; Cecchelli R; Vivien D; Touzani O; Ali C
    Stroke; 2005 May; 36(5):1065-70. PubMed ID: 15817895
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intraarterial recombinant tissue plasminogen activator for ischemic stroke: an accelerating dosing regimen.
    Qureshi AI; Suri MF; Shatla AA; Ringer AJ; Fessler RD; Ali Z; Guterman LR; Hopkins LN
    Neurosurgery; 2000 Aug; 47(2):473-6; discussion 477-9. PubMed ID: 10942026
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Albumin ameliorates tissue plasminogen activator-mediated blood-brain barrier permeability and ischemic brain injury in rats.
    Tang J; Li YJ; Mu J; Li Q; Yang DY; Xie P
    Neurol Res; 2009 Mar; 31(2):189-94. PubMed ID: 19298760
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pharmacological effects of the spin trap agents N-t-butyl-phenylnitrone (PBN) and 2,2,6, 6-tetramethylpiperidine-N-oxyl (TEMPO) in a rabbit thromboembolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.
    Lapchak PA; Chapman DF; Zivin JA
    Stroke; 2001 Jan; 32(1):147-53. PubMed ID: 11136930
    [TBL] [Abstract][Full Text] [Related]  

  • 74. ADAMTS13 cleavage efficiency is altered by mutagenic and, to a lesser extent, polymorphic sequence changes in the A1 and A2 domains of von Willebrand factor.
    Pruss CM; Notley CR; Hegadorn CA; O'Brien LA; Lillicrap D
    Br J Haematol; 2008 Nov; 143(4):552-8. PubMed ID: 18986390
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Protease-independent action of tissue plasminogen activator in brain plasticity and neurological recovery after ischemic stroke.
    Pu H; Shi Y; Zhang L; Lu Z; Ye Q; Leak RK; Xu F; Ma S; Mu H; Wei Z; Xu N; Xia Y; Hu X; Hitchens TK; Bennett MVL; Chen J
    Proc Natl Acad Sci U S A; 2019 Apr; 116(18):9115-9124. PubMed ID: 30996120
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Caveolin-1 mediates tissue plasminogen activator-induced MMP-9 up-regulation in cultured brain microvascular endothelial cells.
    Jin X; Sun Y; Xu J; Liu W
    J Neurochem; 2015 Mar; 132(6):724-30. PubMed ID: 25683686
    [TBL] [Abstract][Full Text] [Related]  

  • 77. MicroRNA-126-3p attenuates blood-brain barrier disruption, cerebral edema and neuronal injury following intracerebral hemorrhage by regulating PIK3R2 and Akt.
    Xi T; Jin F; Zhu Y; Wang J; Tang L; Wang Y; Liebeskind DS; He Z
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):144-151. PubMed ID: 29042193
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hematoma expansion in experimental intracerebral hemorrhage is not altered by peracute treatment with recombinant tissue plasminogen activator.
    Pfeilschifter W; Kashefiolasl S; Lauer A; Steinmetz H; Foerch C
    Neuroscience; 2013 Oct; 250():181-8. PubMed ID: 23856067
    [TBL] [Abstract][Full Text] [Related]  

  • 79. N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Augments Thrombolysis of tPA (Tissue-Type Plasminogen Activator) in Aged Rats After Stroke.
    Li C; Zhang L; Wang C; Teng H; Fan B; Chopp M; Zhang ZG
    Stroke; 2019 Sep; 50(9):2547-2554. PubMed ID: 31387512
    [TBL] [Abstract][Full Text] [Related]  

  • 80. VWF-targeted thrombolysis to overcome rh-tPA resistance in experimental murine ischemic stroke models.
    van Moorsel MVA; de Maat S; Vercruysse K; van Leeuwen EM; Jacqmarcq C; Bonnard T; Vivien D; van der Worp HB; Dijkhuizen RM; Maas C
    Blood; 2022 Dec; 140(26):2844-2848. PubMed ID: 35960811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.